AXL and non-small cell lung carcinoma: While initial studies were performed in a cetuximab-resistant model of non-small cell lung cancer (NSCLC), similar results were observed in models of HNSCC, indicating a more global role of Axl-EGFR-mediated resistance to cetuximab in solid tumors [61].